Maryland Venture Fund has invested $500,000 in Gaithersburg, Md.-based Cytomedix, a regenerative medicine company currently focused on its AutoloGel System for using platelet-rich plasma to heal wounds, according to Maryland Business News. The investment is through the state's Maryland Department of Business and Economic Development InvestMaryland program. Cytomedix is working on a $27.5 million capital campaign, and is looking to add 13 employees and increase worldwide marketing, according to the report.
In addition to the AutologGel System, Cytomedix produces the Angel Whole Blood Separation System for orthopedic and surgical uses.
More Articles on Devices:
OrthoData Receives $250k Investment for Developing Spine Technologies
Stryker Unveiled Iconix All Suture Device for Shoulder, Hip Arthroscopy
Biomaterials Market Estimated at $88.4B by 2017
In addition to the AutologGel System, Cytomedix produces the Angel Whole Blood Separation System for orthopedic and surgical uses.
More Articles on Devices:
OrthoData Receives $250k Investment for Developing Spine Technologies
Stryker Unveiled Iconix All Suture Device for Shoulder, Hip Arthroscopy
Biomaterials Market Estimated at $88.4B by 2017